Great Lakes Advisors, LLC Ovid Therapeutics Inc. Transaction History

Great Lakes Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$2.65 - $3.49 $40,269 - $53,034	-15,196 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$3.13 - $3.73 $3,709 - $4,420	-1,185 Reduced 7.23%	15,196 $49,000
Q3 2021 Nov 09, 2021	SELL	$3.31 - $4.04 $314 - $383	-95 Reduced 0.58%	16,381 $55,000
Q2 2021 Aug 11, 2021	SELL	$3.3 - $4.49 $1,376 - $1,872	-417 Reduced 2.47%	16,476 $64,000
Q1 2021 May 03, 2021	BUY	$2.42 - $4.47 $40,881 - $75,511	16,893 New	16,893 $68,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.